CMI for Expert Breast MRI at St. Luke’s Campus, Utica For Scheduling Call: 792-1985

St. Luke’s CMI is An American College of Radiology Accredited Facility

Fast Facts

What is required to order?

A previous mammogram or ultrasound is required. Also, reports and films from related imaging studies including biopsies of the breast are required. Patient should be scheduled one week after last menstrual period.

How do I schedule a Breast MRI?

Call 792-1985 to speak to our scheduling department.

Where is Breast MRI offered?

Breast MRI is offered at our St. Luke’s Campus.


Breast MRI is primarily used for determining extent of disease, monitoring response to therapy and screening high risk patients. The exam is a non-invasive procedure that uses magnets and radio waves to produce images of the breast. No ionizing radiation is used. Breast MRI can also be used in addition to mammography and/or ultrasound to better evaluate dense breast tissue and palpable lumps. In general, breast MRI is a complement to a diagnostic mammogram and does not replace screening mammograms.

Providing Breast Magnetic Resonance Imaging (MRI) with Computer-Aided-Detection (CAD):

Improved Efficiencies in Study Analysis

DynaCad is a digital imaging workstation with a set of computer-assisted diagnosis (CAD) tools for performing real-time image analysis and interventional

procedure planning. DynaCad provides radiologists with a more powerful tool for viewing and analysis with significantly increased diagnostic confidence.


Breast MRI can be used for determining extent of disease,

monitoring response to therapy and screening high risk patients.

Approximately 8.5 million women in the U.S. are at high risk for breast cancer.

Additionally, the American Cancer Society guidelines recommends MRI as an effective and sensitive adjunct to mammography.

DynaCADTM improves efficiency, standardization and quality in breast MR imaging.


Clinical Indications for Contrast-Enhanced Breast MRI:

  • Patients who are at high risk for breast cancer, (Prior atypia, LCIS and/or genetic risk).
  • Cases where diagnosis is inconclusive, even after standard work-up.
  • Evaluation of post-operative patient when scar tissue cannot be differentiated from tumors.
  • Patients with rupture of breast implants.
  • Determination of the extent of disease in patients with known malignancy.
  • Patients with positive axilliary lymph nodes but no known primary malignancy.